Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
72.71
Dollar change
+1.15
Percentage change
1.61
%
IndexRUT P/E42.25 EPS (ttm)1.72 Insider Own2.38% Shs Outstand57.31M Perf Week0.54%
Market Cap4.20B Forward P/E22.54 EPS next Y3.23 Insider Trans-2.15% Shs Float56.38M Perf Month2.32%
Income100.18M PEG3.67 EPS next Q0.76 Inst Own97.12% Short Float / Ratio1.61% / 2.95 Perf Quarter11.35%
Sales1.22B P/S3.44 EPS this Y9.76% Inst Trans2.03% Short Interest0.91M Perf Half Y-13.80%
Book/sh21.30 P/B3.41 EPS next Y8.83% ROA5.82% Target Price86.25 Perf Year0.99%
Cash/sh1.05 P/C69.14 EPS next 5Y11.50% ROE8.64% 52W Range62.58 - 85.62 Perf YTD2.96%
Dividend- P/FCF58.92 EPS past 5Y18.63% ROI6.38% 52W High-15.08% Beta0.90
Dividend %- Quick Ratio1.50 Sales past 5Y9.82% Gross Margin42.56% 52W Low16.19% ATR1.57
Employees6846 Current Ratio3.13 Sales Q/Q10.04% Oper. Margin9.80% RSI (14)59.53 Volatility1.78% 1.95%
OptionableYes Debt/Eq0.29 EPS Q/Q66.89% Profit Margin8.20% Rel Volume0.86 Prev Close71.56
ShortableYes LT Debt/Eq0.28 EarningsOct 26 AMC Payout0.00% Avg Volume306.98K Price72.71
Recom1.62 SMA201.87% SMA505.93% SMA200-1.53% Volume262,578 Change1.61%
Date Action Analyst Rating Change Price Target Change
Dec-20-22Downgrade Canaccord Genuity Buy → Hold $73 → $72
Jan-05-21Upgrade Needham Hold → Buy $65
Sep-28-20Upgrade Wells Fargo Underweight → Equal Weight $42
Feb-25-20Downgrade Barrington Research Outperform → Mkt Perform
Feb-03-20Upgrade Raymond James Mkt Perform → Outperform $43
Dec-12-19Downgrade Wells Fargo Market Perform → Underperform $26
Sep-24-19Initiated Oppenheimer Outperform
Sep-10-19Downgrade Raymond James Outperform → Mkt Perform
Jul-26-19Downgrade Wells Fargo Outperform → Market Perform
Jul-26-19Downgrade Needham Buy → Hold
Nov-15-23 07:28AM
Nov-01-23 09:55AM
Oct-31-23 11:40AM
Oct-30-23 01:37AM
Oct-27-23 12:20PM
11:16AM Loading…
11:16AM
10:51AM
Oct-26-23 07:30PM
05:50PM
05:48PM
04:40PM
04:05PM
07:52AM
Oct-25-23 10:21AM
Oct-12-23 11:55AM
11:40AM Loading…
Oct-10-23 11:40AM
09:25AM
Oct-05-23 11:05AM
09:25AM
Sep-19-23 09:00AM
Sep-07-23 07:22AM
Sep-06-23 09:25AM
Aug-30-23 12:46PM
Aug-15-23 01:20PM
Aug-10-23 07:58AM
Aug-08-23 06:50AM
Aug-03-23 09:25AM
Jul-26-23 12:07PM
Jul-25-23 08:00PM
05:45PM
04:43PM Loading…
04:43PM
04:05PM
Jul-21-23 06:51AM
Jul-13-23 11:56AM
Jul-11-23 11:40AM
Jul-07-23 07:20AM
Jul-06-23 01:11PM
Jul-03-23 07:51AM
Jun-26-23 10:50AM
Jun-22-23 11:40AM
Jun-21-23 08:00PM
11:35AM
Jun-19-23 10:24AM
Jun-14-23 11:51AM
11:22AM
Jun-13-23 01:59PM
11:22AM
Jun-09-23 01:39PM
Jun-08-23 04:01PM
12:44PM
Jun-07-23 04:23PM
01:53PM
12:52PM
Jun-06-23 12:37PM
10:20AM
Jun-05-23 02:12PM
11:45AM
Jun-02-23 12:44PM
Jun-01-23 11:28AM
11:17AM
10:14AM
May-31-23 12:07PM
12:04PM
May-26-23 11:31AM
10:55AM
May-25-23 02:30PM
02:29PM
May-24-23 01:42PM
10:14AM
May-23-23 11:23AM
11:04AM
11:01AM
May-22-23 11:13AM
11:10AM
10:48AM
May-19-23 11:39AM
10:48AM
08:41AM
May-18-23 01:12PM
01:09PM
10:50AM
May-17-23 02:15PM
09:40AM
May-16-23 02:35PM
02:32PM
May-15-23 01:10PM
May-11-23 01:04PM
10:08AM
May-10-23 10:53AM
May-04-23 10:53AM
May-03-23 11:35AM
May-01-23 10:34AM
Apr-28-23 01:27PM
12:00PM
09:15AM
Apr-27-23 08:21AM
Apr-26-23 09:00PM
08:00PM
05:45PM
04:05PM
Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger, and William Padilla in July 1987 and is headquartered in South Jordan, UT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LAMPROPOULOS FRED PPRESIDENT AND CEOAug 25Option Exercise28.20200,0005,640,0001,167,916Aug 29 06:08 PM
LAMPROPOULOS FRED PPRESIDENT AND CEOAug 25Option Exercise28.206,000169,20012,888Aug 29 06:08 PM
Peterson NeilCHIEF OPERATING OFFICERAug 22Option Exercise28.208,000225,6008,000Aug 23 11:32 AM
Peterson NeilCHIEF OPERATING OFFICERAug 22Sale67.918,000543,2880Aug 23 11:32 AM
ANDERSON A SCOTTDirectorAug 09Option Exercise50.5025,0001,262,50071,397Aug 11 05:30 PM
ANDERSON A SCOTTDirectorAug 09Sale69.4022,1801,539,29249,217Aug 11 05:30 PM
Peterson NeilCHIEF OPERATING OFFICERMar 16Option Exercise28.208,000225,6008,000Mar 20 04:44 PM
Peterson NeilCHIEF OPERATING OFFICERMar 16Sale68.758,000550,0000Mar 20 04:44 PM
LAMPROPOULOS FRED PPRESIDENT AND CEOMar 14Sale68.2624,9771,705,052967,916Mar 16 06:01 PM
Voigt Michel JamesCHIEF HUMAN RESOURCES OFFICERMar 14Sale68.312,000136,620515Mar 15 01:34 PM
Ward LynneDirectorMar 08Option Exercise34.462,00068,92017,549Mar 10 06:32 PM
Ward LynneDirectorMar 08Sale66.7111,585772,7895,964Mar 10 06:32 PM
ANDERSON A SCOTTDirectorMar 06Option Exercise29.2015,000438,00062,135Mar 08 12:49 PM
ANDERSON A SCOTTDirectorMar 06Sale66.7415,0001,001,16047,135Mar 08 12:49 PM
Parra Raul Jr.CFO AND TREASURERMar 03Sale70.001,02371,6106,688Mar 07 03:05 PM
Parra Raul Jr.CFO AND TREASURERMar 02Option Exercise37.716,000226,26019,697Mar 03 05:54 PM
LAMPROPOULOS FRED PPRESIDENT AND CEOMar 02Sale69.8619,1761,339,616992,893Mar 02 08:18 PM
Parra Raul Jr.CFO AND TREASURERMar 02Sale70.0011,986839,0207,711Mar 03 05:54 PM
LAMPROPOULOS FRED PPRESIDENT AND CEOMar 01Sale70.171,483104,0681,012,069Mar 02 08:18 PM